Lymphangiogenesis in breast cancer is associated with non-sentinel lymph node metastases in sentinel node positive patients

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11171-7. eCollection 2015.

Abstract

Axillary lymph node dissection (ALND) is not suggested in breast cancer patients with negative sentinel lymph node (SLN) biopsies, and SLN is the only positive node in 40-70% of the remaining cases. To distinguish a subgroup in which ALND would be omitted, we investigated the role of lymphangiogenesis in primary breast cancer as a risk factor for distal lymph node involvements in patients with positive SLNs. 86 patients were included in this study. The frequency of proliferative lymphatic endothelial cells (LECP%) was evaluated in each specimen after immunohistochemical double staining for D2-40 and Ki-67. Larger primary tumor size, increased number of positive SLNs, lymphatic vessel invasion and LECP% were significantly associated with non-SLN metastases in the univariate analysis, but only LECP% retained significance in the multivariate model. A positive correlation between LECP% and lymphatic vessel invasion was also revealed. Our study confirmed the important role of lymphangiogenesis in tumor spread, and suggested that LECP% is a promising predictor for additional axillary lymph node involvements.

Keywords: Lymphangiogenesis; breast cancer; metastasis; sentinel lymph node.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal, Murine-Derived
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / surgery
  • Female
  • Humans
  • Immunohistochemistry / methods
  • Ki-67 Antigen / analysis
  • Lymph Node Excision
  • Lymph Nodes / chemistry
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Lymphangiogenesis*
  • Lymphatic Metastasis
  • Lymphatic Vessels / chemistry
  • Lymphatic Vessels / pathology*
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • Patient Selection
  • Predictive Value of Tests
  • Sentinel Lymph Node Biopsy

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Ki-67 Antigen
  • monoclonal antibody D2-40